Literature DB >> 31832935

Commentary: Cancer after the OAGB-MGB.

Robert Rutledge1, Mervyn Deitel2, Miguel A Carbajo3, Enrique Luque-de-Leon4, Sonja Chiappetta5, Aatif Inam6, Karl Rheinwalt7, Arun Prasad8, David E Hargroder9, Vladimir Samoylov10, M Mahir Ozmen11, Chetan Parmar12, António Albuquerque13, Gurvinder Jammu14, Murat Ustun15, Nasser Sakran16, Recep Aktimur17, Amir Khan18, Yasser Hamza19, Adriana Rotundo20, Marc Focquet21, Michael Van den Bossche22, Om Tantia23, Francesco Greco24, Midhat Abu Sneineh25, Francisco Barrera Rodriguez26, Mario Musella27, Miroslav Ilić28, Imran Abbas29.   

Abstract

Mesh：

Year:  2020        PMID： 31832935     DOI： 10.1007/s11695-019-04313-5

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


× No keyword cloud information.
  10 in total

1.  A 6-year experience with 1,054 mini-gastric bypasses-first study from Indian subcontinent.

Authors:  K S Kular; N Manchanda; R Rutledge
Journal:  Obes Surg       Date:  2014-09       Impact factor: 4.129

2.  The mini-gastric bypass: experience with the first 1,274 cases.

Authors:  R Rutledge
Journal:  Obes Surg       Date:  2001-06       Impact factor: 4.129

Review 3.  The Mini-Gastric Bypass original technique.

Authors:  Robert Rutledge; Kuldeepak Kular; Naveen Manchanda
Journal:  Int J Surg       Date:  2018-11-24       Impact factor: 6.071

4.  Effects of omega-loop bypass on esophagogastric junction function.

Authors:  Salvatore Tolone; Stefano Cristiano; Edoardo Savarino; Francesco Saverio Lucido; Domenico Ivan Fico; Ludovico Docimo
Journal:  Surg Obes Relat Dis       Date:  2015-03-27       Impact factor: 4.734

5.  Association Between Subtotal Gastrectomy with Billroth II Anastomosis and Coronary Heart Disease.

Authors:  Chien-Hua Chen; Cheng-Li Lin; Yu-Shu Cheng; Long-Bin Jeng
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

6.  Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial.

Authors:  Maud Robert; Philippe Espalieu; Elise Pelascini; Robert Caiazzo; Adrien Sterkers; Lita Khamphommala; Tigran Poghosyan; Jean-Marc Chevallier; Vincent Malherbe; Elie Chouillard; Fabian Reche; Adriana Torcivia; Delphine Maucort-Boulch; Sylvie Bin-Dorel; Carole Langlois-Jacques; Dominique Delaunay; François Pattou; Emmanuel Disse
Journal:  Lancet       Date:  2019-03-06       Impact factor: 79.321

7.  Gastric bypass in obesity.

Authors:  E E Mason; C Ito
Journal:  Surg Clin North Am       Date:  1967-12       Impact factor: 2.741

8.  Experience with an Enhanced Recovery After Surgery (ERAS) Program for Bariatric Surgery: Comparison of MGB and LSG in 374 Patients.

Authors:  Marie-Cécile Blanchet; Benoît Gignoux; Yann Matussière; Alexandre Vulliez; Thomas Lanz; Fabienne Monier; Vincent Frering
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

9.  Does Sleeve Gastrectomy Expose the Distal Esophagus to Severe Reflux?: A Systematic Review and Meta-analysis.

Authors:  Kai Tai Derek Yeung; Nicholas Penney; Leanne Ashrafian; Ara Darzi; Hutan Ashrafian
Journal:  Ann Surg       Date:  2020-02       Impact factor: 12.969

10.  The Development of Diabetes after Subtotal Gastrectomy with Billroth II Anastomosis for Peptic Ulcer Disease.

Authors:  Chien-Hua Chen; Che-Ming Hsu; Cheng-Li Lin; An-Kuo Chou; Long-Bin Jeng
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240
  10 in total
  2 in total

1.  Network Meta-Analysis of Metabolic Surgery Procedures for the Treatment of Obesity and Diabetes.

Authors:  Andrew C Currie; Alan Askari; Ana Fangueiro; Kamal Mahawar
Journal:  Obes Surg       Date:  2021-08-07       Impact factor: 3.479

2.  Evaluation of reflux following sleeve gastrectomy and one anastomosis gastric bypass: 1-year results from a randomized open-label controlled trial.

Authors:  Mario Musella; Antonio Vitiello; Giovanna Berardi; Nunzio Velotti; Marcella Pesce; Giovanni Sarnelli
Journal:  Surg Endosc       Date:  2020-12-02       Impact factor: 4.584
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.